Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in ABT — Abbott Laboratories

CIK 1595888 NEW YORK, NY
Back to ABT Full portfolio

Position in ABT

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$16,429,457
+$7,380,764 QoQ
Shares Held
160,022
+121.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Mar 31, 2026
CallValue
$129,292,331
CallShares
1,259,300
PutValue
$87,320,835
PutShares
850,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $517,213,370 across 57 Medical Devices names. ABT ranks #6 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 4,032,117 $253,015,341
2 DXCM
Dexcom Inc
 741,669 $46,576,812
3 ESTA
Establishment Labs Holdings Inc.
 627,700 $35,640,805
4 EW
Edwards Lifesciences Corp
 390,333 $31,257,865
5 MDT
Medtronic plc
 349,874 $30,316,580
6 ABT
Abbott Laboratories
This page 		160,022 $16,429,457
7 IRTC
iRhythm Holdings, Inc.
 112,864 $13,320,209
8 ATEC
Alphatec Holdings, Inc.
 878,549 $9,558,612

All Filings in ABT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $87,320,835 850,500
2026-03-31 $129,292,331 1,259,300
2026-03-31 $16,429,457 160,022
2025-12-31 $38,626,907 308,300
2025-12-31 $127,119,234 1,014,600
2025-12-31 $9,048,693 72,222
2025-09-30 $27,538,064 205,600
2025-09-30 $61,599,006 459,900
2025-09-30 $23,871,455 178,225
2025-06-30 $638,158 4,692
2025-06-30 $80,137,092 589,200
2025-06-30 $11,656,057 85,700
2025-03-31 $6,765,150 51,000
2025-03-31 $71,591,205 539,700
2025-03-31 $52,258,926 393,961
2024-12-31 $10,881,182 96,200
2024-12-31 $35,915,592 317,528
2024-12-31 $60,559,094 535,400
2024-09-30 $45,649,604 400,400
2024-09-30 $16,447,538 144,264
2024-09-30 $18,754,645 164,500
2024-06-30 $93,252,262 897,433
2024-03-31 $42,723,543 375,889
2023-12-31 $72,819,669 661,576
2023-09-30 $31,700,844 327,319
2023-06-30 $49,508,270 454,121
2023-03-31 $20,891,050 206,311
2022-12-31 $2,738,382 24,942
2022-09-30 $18,096,151 187,021
2022-06-30 $76,201,350 701,347
2022-03-31 $21,980,752 185,711
2022-03-31 $53,451,376 451,600
2022-03-31 $122,739,320 1,037,000
2021-12-31 $57,013,774 405,100
2021-12-31 $25,917,552 184,152
2021-12-31 $123,766,756 879,400
2021-09-30 $11,690,735 98,965
2021-09-30 $37,730,722 319,400
2021-09-30 $86,636,542 733,400
2021-06-30 $50,209,283 433,100
2021-06-30 $55,550,524 479,173
2021-06-30 $30,408,439 262,300
2021-03-31 $45,598,880 380,498
2021-03-31 $47,959,968 400,200
2021-03-31 $8,724,352 72,800
2020-12-31 $64,872,825 592,500
2020-12-31 $8,573,067 78,300
2020-12-31 $6,776,993 61,896
2020-09-30 $4,020,615 36,944
2020-09-30 $64,264,115 590,500

Report a Problem

Category
Description
Email (optional, for follow-up)